Consistent with these findings, shRNA-mediated knockdown of PKM2 in HepG2 cells resulted in a significant reduction in BCL-2 levels, concomitant with decreased tumor growth upon subcutaneous inoculation in BALB/c nude mice [109]. The gene discussed is PKM; the disease is neoplasm.